Elevated transglutaminase 2 activity is associated with hypoxia-induced experimental pulmonary hypertension in mice.
about
Therapeutic approaches for celiac diseaseTransglutaminase 2-mediated serotonylation in pulmonary hypertensionFungus-derived hydroxyl radicals kill hepatic cells by enhancing nuclear transglutaminase.Dihydroisoxazole inhibitors of Anopheles gambiae seminal transglutaminase AgTG3Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine: IMPLICATIONS FOR CELIAC DISEASE.Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography.How cells channel their stress: Interplay between Piezo1 and the cytoskeleton.Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease.Tissue transglutaminase promotes serotonin-induced AKT signaling and mitogenesis in pulmonary vascular smooth muscle cells.Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation.Update on novel targets and potential treatment avenues in pulmonary hypertension.Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension.Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2.Calpain-1 regulates platelet function in a humanized mouse model of sickle cell disease.Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model.Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension.
P2860
Q26825413-0F885547-D47A-423B-BCF5-D147FB03AB49Q27027862-31F1C14D-032C-4FEE-A222-631BF398378BQ33881464-FCE4C4B2-06E3-4F93-BD54-B54C46B5A65CQ33959419-8F0F20BB-8A8B-43A5-9B49-0C264EDAA1FBQ35053942-B751F7DA-6898-4099-B640-BC73B91EAD52Q38724906-E03ABFD3-E977-4854-94D7-AB6FA2FCDBE4Q38886629-B73FE351-8C84-4F12-B9AE-19F27AFEFCA3Q39414046-D547350E-C824-47D4-A849-9B6B38239FAFQ40254093-0169A352-3A71-4837-A56F-C8B79905E732Q41876916-1AF12277-872E-44EB-B55D-34FAF0CC86CDQ42272148-93C10E6D-A70C-4285-BEE0-569F08B9F666Q42547773-CC43A39A-2935-4D0A-99B1-40AD7538722EQ42784219-F6A4CB58-1B8C-44F3-957B-C0A2BC20F940Q46273115-604E73A7-2106-45CA-A2B2-0E6FDE714C17Q47228617-E4FA89EF-4DFA-478A-BB4B-F44EB16C620DQ47666229-4BCA806D-3961-448F-B235-2C7CC8A7138AQ52566925-9DAF50C6-1EE8-460C-A19A-20C844EB0DACQ55030374-E86B2FEE-D52C-4B7C-8957-48AF77C01B98Q55259961-54B6664E-03AB-49E0-AF13-570D76F729D1
P2860
Elevated transglutaminase 2 activity is associated with hypoxia-induced experimental pulmonary hypertension in mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Elevated transglutaminase 2 ac ...... ulmonary hypertension in mice.
@en
type
label
Elevated transglutaminase 2 ac ...... ulmonary hypertension in mice.
@en
prefLabel
Elevated transglutaminase 2 ac ...... ulmonary hypertension in mice.
@en
P2093
P2860
P356
P1433
P1476
Elevated transglutaminase 2 ac ...... ulmonary hypertension in mice.
@en
P2093
Barry Fanburg
Chaitan Khosla
Cornelius Klöck
Deniz Toksoz
Krishna Penumatsa
Nicholas Hill
Rod Warburton
Thomas R DiRaimondo
Zachary Herrera
P2860
P304
P356
10.1021/CB4006408
P577
2013-11-05T00:00:00Z